Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”

Guardado en:
Detalles Bibliográficos
Autores principales: Jeffrey E. Gold, David J. Hurley, Balázs Rada, William H. Baumgartl, Larry P. Tilley, Warren E. Licht
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/3b05e611f5034c68b66b7ba041668756
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3b05e611f5034c68b66b7ba041668756
record_format dspace
spelling oai:doaj.org-article:3b05e611f5034c68b66b7ba0416687562021-11-03T18:15:38ZReply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”2161-21292150-751110.1128/mBio.03682-20https://doaj.org/article/3b05e611f5034c68b66b7ba0416687562021-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.03682-20https://doaj.org/toc/2161-2129https://doaj.org/toc/2150-7511Jeffrey E. GoldDavid J. HurleyBalázs RadaWilliam H. BaumgartlLarry P. TilleyWarren E. LichtAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Jeffrey E. Gold
David J. Hurley
Balázs Rada
William H. Baumgartl
Larry P. Tilley
Warren E. Licht
Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
format article
author Jeffrey E. Gold
David J. Hurley
Balázs Rada
William H. Baumgartl
Larry P. Tilley
Warren E. Licht
author_facet Jeffrey E. Gold
David J. Hurley
Balázs Rada
William H. Baumgartl
Larry P. Tilley
Warren E. Licht
author_sort Jeffrey E. Gold
title Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
title_short Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
title_full Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
title_fullStr Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
title_full_unstemmed Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
title_sort reply to marakasova and baranova, “mmr vaccine and covid-19: measles protein homology may contribute to cross-reactivity or to complement activation protection”
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/3b05e611f5034c68b66b7ba041668756
work_keys_str_mv AT jeffreyegold replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT davidjhurley replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT balazsrada replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT williamhbaumgartl replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT larryptilley replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT warrenelicht replytomarakasovaandbaranovammrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
_version_ 1718445450292363264